|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B
Levels in Rat Skeletal Muscle in a Fiber-Type Dependent Manner
1 Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
2 Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, PA, USA
* To whom correspondence should be addressed. E-mail: odohertyr{at}dom.pitt.edu.
Increased activity of pro-inflammatory/stress pathways has been implicated in the pathogenesis of insulin resistance in obesity. However, the effects of obesity on the activity of these pathways in skeletal muscle, the major insulin sensitive tissue by mass, are poorly understood. Furthermore, the mechanisms that activate pro-inflammatory/stress pathways in obesity are unknown. The current study addressed in rats the effects of diet-induced obesity (DIO, 6 weeks of high fat feeding) and acute (6h) hyperlipidemia (HL) on activity of IKK/I
B/NF
B, JNK, and p38 MAPK in three skeletal muscles differing in fiber type [superficial vastus (VAS, fast twitch-glycolytic), soleus (SOL, slow twitch-oxidative) and gastrocnemius (GAS, mixed)]. DIO decreased the levels of the NF
B inhibitor, I
B
, in VAS (24±3%, P=0.001, n=8) but not in SOL or GAS compared to standard chow fed controls. Similar to DIO, HL decreased I
B
levels in VAS (26±5%, P=0.006, n=6) and in GAS (15±4%, P=0.01, n=7) but not in SOL compared to saline-infused controls. Importantly, the fiber-type dependent effects on I
B
levels could not be explained by differential accumulation of triglyceride in SOL and VAS . HL, but not DIO, decreased phospho-p38 MAPK levels in VAS (41±7% P=0.004, n=6) but not in SOL or GAS. Finally, skeletal muscle JNK activity was unchanged by DIO or HL. We conclude that diet-induced obesity and acute hyperlipidemia reduce I
B
levels in rat skeletal muscle in a fiber-type dependent manner.
This article has been cited by other articles:
![]() |
A. J. Hoy, A. E. Brandon, N. Turner, M. J. Watt, C. R. Bruce, G. J. Cooney, and E. W. Kraegen Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E67 - E75. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Yaspelkis III, I. A. Kvasha, and T. Y. Figueroa High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKK{alpha}/{beta} phosphorylation and decreases PI-3 kinase activity in muscle Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1709 - R1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liang, B. Balas, P. Tantiwong, J. Dube, B. H. Goodpaster, R. M. O'Doherty, R. A. DeFronzo, A. Richardson, N. Musi, and W. F. Ward Whole body overexpression of PGC-1{alpha} has opposite effects on hepatic and muscle insulin sensitivity Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E945 - E954. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R673 - R680. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Polkinghorne, Q. Lau, G. J. Cooney, E. W. Kraegen, and M. E. Cleasby Local activation of the I{kappa}K-NF-{kappa}B pathway in muscle does not cause insulin resistance Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E316 - E325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sriwijitkamol, C. Christ-Roberts, R. Berria, P. Eagan, T. Pratipanawatr, R. A. DeFronzo, L. J. Mandarino, and N. Musi Reduced Skeletal Muscle Inhibitor of {kappa}B{beta} Content Is Associated With Insulin Resistance in Subjects With Type 2 Diabetes: Reversal by Exercise Training Diabetes, March 1, 2006; 55(3): 760 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Persson From clinical insights to new therapies Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R124 - R125. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |